while kidneys from male donors have better long-term are likely to contribute to these gender-related differences. The present study investigated the role of androgens and their inhiallograft outcome [4] .
bition on the development of chronic allograft nephropathy.
For many years, it has been hypothesized that the imMethods. Male or female Fisher (F344) kidneys were orthopact of donor gender on graft survival may primarily result topically transplanted into intact male Lewis recipients. Anifrom genetically determined differences in allograft size mals were treated either with testosterone, the antiandrogen flutamide, the 5␣-reductase inhibitor finasteride, or vehicle.
and structure, as females have smaller kidneys than Twenty weeks after transplantation animals were harvested males. Therefore, transplantation of a female kidney into for histology, immunohistology, and molecular analysis. a male recipient may be functionally inadequate for the Results. Testosterone treatment resulted in an increased prodemands of the recipient, which results in hyperfiltrationteinuria as well as profound glomerulosclerosis, tubulointerstiinduced glomerular injury and may thus be responsible tial fibrosis, and mononuclear cell infiltration that paralleled enhanced intragraft mRNA levels of transforming growth facfor the reduced allograft survival of female donors [5, 6] . olism, as well as synthesis and release of vasoactive agents, Conclusions. Our data suggest that dihydrotestosterone mecytokines, and other growth factors, which in turn are diates the adverse effects of androgens on chronic allograft capable of altering the progression of renal diseases [7] .
nephropathy. The inhibition of androgens improves long-term allograft outcome after kidney transplantation.
In males, the presence of the major androgen hormone testosterone is widely believed to promote renal injury in several non-transplant animal models of glomeruloChronic allograft nephropathy is the most important sclerosis [8] [9] [10] . In addition, various humoral and cellular cause of late graft loss after kidney transplantation. It immune responses are regulated by sex hormones [11] . is characterized by a progressive deterioration of renal Utilizing ovariectomized female recipients, we refunction associated with nonspecific histopathological cently demonstrated that in the absence of the main sex findings such as glomerulosclerosis, tubular atrophy, inhormones, kidneys derived from female donors deterioterstitial fibrosis, inflammatory cellular infiltration, and rate more rapidly than allografts of male origin [12] . Our intimal thickening of graft arteries [11] . data indicated that testosterone substitution exacerbates Apart from alloantigen-dependent mechanisms, allochronic allograft nephropathy in kidneys of male origin. antigen-independent factors are involved in the rejection There remained a number of open questions: Do these results apply to grafts of male origin only? Does testosterone also tamper renal function in intact males? Finally, athy [transforming growth factor-␤ (TGF-␤) and plateletderived growth factor (PDGF)] affected by these changes? The present study was undertaken to answer these quesaction, we employed the 5␣-reductase inhibitor finasteride to control for effects not mediated by testosterone tions.
itself. 5␣-Reductase converts testosterone to the more potent androgenic steroid dihydrotestosterone.
METHODS

Animals
Functional measurements Every four weeks, body weight was measured and 24-Naive inbred rats (Charles River, Sulzfeld, Germany), weighing 200 to 250 g, were used throughout the experihour urine samples were collected using metabolic cages with a urine-cooling system. Quantitative urine protein ments: male and female Fisher (F344, RT1v1) rats served as donors, whereas male Lewis (Lew, RT1) rats were was nephelometrically determined. Serum and urine creatinine levels as well as hormones were measured and used as recipients. Animals were kept under standard conditions and were fed rat chow and water ad libitum.
creatinine clearance was calculated at the end of the study. All experiments were approved by a governmental committee on animal welfare.
After 20 weeks, rats were anesthetized with diethylether, and immediately thereafter, intra-aortic blood Renal transplantation pressure was measured (Sirecust 404, Siemens, Dortmund, Germany). Animals then were bled and the transUnder ketamine (Ketamin, 100 mg/kg IP; CP-Pharma, Burgdorf, Germany) and xylacine (Rompun, 10 mg/kg planted kidney was removed. Samples were snap frozen in liquid nitrogen for immunohistological staining and IP; Bayer, Leverkusen, Germany) anesthesia, the left donor kidney was removed, cooled, and positioned ormolecular analysis or fixed in formalin for light microscopical evaluation. thotopically into the recipient. Donor and recipient renal artery, vein, and ureter were anastomosed end to end Histology and immunohistology with 10-0 Prolene sutures. No ureteral stent was used. To overcome infectious complications caused by operation, For histology, kidney tissues were fixed in 4% buffered formalin, embedded in paraffin, and stained with either rats received Cephtriaxone (Rocephin; 20 mg/kg/day, intramuscularly; Hoffmann-la Roche AG, Grenzachhematoxylin/eosin or periodic acid-Schiff (PAS). Glomerulosclerosis was defined as a collapse of capillaries, adheWyhlen, Germany) on the first postoperative day. Animals were treated with low-dose cyclosporine A (1.5 mg/ sion of the obsolescent segment of Bowman's capsule and entrapment of hyaline in the mesangium [13] . At kg/day SC; Novartis GmbH, Nü rnberg, Germany) over the first ten days after transplantation to overcome an least 200 glomeruli were counted per kidney section and the proportion of sclerosed to total glomeruli was exinitial episode of acute rejection. The contralateral native kidney was removed on the tenth postoperative day.
pressed as a percentage (glomerulosclerosis index). Glomerulopathy, tubular atrophy, interstitial fibrosis and vasExperimental design cular intimal proliferation were quantified according to the Banff 1997 classification [14] and scored 0 to 3, reIntact male recipients were transplanted either with a male or a female kidney. Animals were assigned to the spectively. For immunohistology, cryostat sections (4 m) were following eight experimental groups (N Ն 6 per group) according to donor gender and treatment: male graft, fixed in acetone, air dried, and individually stained with primary monoclonal mouse-derived antibodies against testosterone treatment (M/T); male graft, vehicle treatment (M/V); male graft, flutamide treatment (M/FL); monocytes/macrophages (ED1) and CD5ϩ T-lymphocytes (OX19; Serotec Camon Labor-Service GmbH, Wiesmale graft and finasteride treatment (M/FI); female graft, testosterone treatment (F/T); female graft, vehicle treatbaden, Germany). After incubation with primary antibody, sections were incubated with rabbit anti-mouse ment (F/V); female graft, flutamide treatment (F/FL); and female graft and finasteride treatment (F/FI). TesIgG and thereafter with the alkaline phosphatase antialkaline phosphatase (APAAP) complex (Dako A/S, Hamtosterone (0.5 mg/kg), testosterone receptor blocker flutamide (25 mg/kg), and 5␣-reductase inhibitor finasteride burg, Germany). Cells staining positive were counted and expressed as cells per field of view (cells/fv). At least (25 mg/kg) were dissolved in sesame oil and subcutaneously administered every second day (0.1 mL) following 20 fields of view per section and per specimen were evaluated at ϫ400 magnification. transplantation until harvesting. Control animals were given sesame oil alone.
RNase protection assay Grafts of male and female gender were used to control for the effects of donor gender. The testosterone recepTotal RNA was extracted from the kidney tissues according to the modified guanidine-isothiocyanate prepator antagonist flutamide was applied to block the effects of testosterone at the receptor site. Since testosterone ration [15] and stored at Ϫ80ЊC until further processing. Intragraft mRNA expression specific for transforming is not the active form of the hormone at many sites of growth factor-␤1 (TGF-␤1) and glyceraldehyde-3-phosgiven as the ratio of intensity of growth factors to ␤-actin phate dehydrogenase (GAPDH) was determined by mRNA. RNase protection assay with the use of in vitro tranStatistical analysis scription and RPA Kit (Pharmingen, Becton Dickinson GmbH, Hamburg, Germany) according to the protocol Data are presented as mean Ϯ SEM. Parametric data provided by the manufacturer. Briefly, antisense RNA were compared using one-way analysis of variance, folprobes were prepared with the use of T7 RNA polymerase lowed by a multiple pair-wise comparison according to transcription in the presence of [␣ 32 P]UTP. Radiolabeled the Newman-Keuls test. Nonparametric data were tested RNA probes were then extracted with Tris-saturated using the Kruskal-Wallis one-way analysis of ranks. A phenol and chloroform:isoamyl alcohol and precipitated P value of less than 0.05 was considered significant. with ethanol. Probe activity was measured in a scintillation counter. Thereafter, 10 g total RNA from each RESULTS samples were hybridized together with a specific radiolabeled antisense probe (activity Ͼ3 ϫ 10 5 cpm) at 56ЊC Functional data overnight. After purification and precipitation, protected Proteinuria did not differ significantly between vehifragments were separated by electrophoresis on a 5%
cle-treated animals (M/V, F/V) according to the origin polyacrylamide gel. Intensities of the protected bands of the kidney by week 20 ( Fig. 1) . In contrast, animals were quantified by a phosphorimaging analyzer (Fujitreated with testosterone had developed an increased BAS 1500, Dü sseldorf, Germany), and the ratios of the urinary protein excretion. The level of protein excretion investigated genes to GAPDH (internal control) were was comparable throughout the period observed becalculated.
tween flutamide-, finasteride-, and vehicle-treated rats independent of donor gender.
Reverse transcriptase-polymerase chain reaction
Serum creatinine levels, creatinine clearance, hematoIsolated RNA was amplified by reverse transcription crit, and mean arterial blood pressure did not signifi-(RT) with an Oligo(dT) [12] [13] [14] [15] [16] [17] [18] primer (GIBCO/BRL, Karlscantly differ between the groups (Table 1) . However, ruhe, Germany). One microgram of total RNA was there was a tendency towards an increased blood presadded to 0.5 g of primer. A reaction mixture containing sure in animals that had received a female kidney as the RT buffer solution [(GIBCO/BRL); adenosine, thycompared with those with a graft of male origin. midine, guanosine, and cytosine triphosphate each in a With respect to sex hormones, there was a trend toconcentration of 0.2 mmol/L/L (Boehringer Mannheim wards increased serum testosterone levels in testosterGmbH, Mannheim, Germany); 0.5 L of 40 U/L of one-and flutamide-treated animals as compared with recombinant ribonuclease inhibitor (Promega) and 0.5 L vehicle-treated rats. Finasteride did not significantly inof 200 U/L M-MLV reverse transcriptase (GIBCO/ fluence these levels. BRL)] was added and the first chain reaction allowed At the beginning as well as during follow-up, body to proceed (42ЊC, 1 hour). The reaction was halted by weights were comparable in all groups (Table 2) . Simiheating to 95ЊC for five minutes followed by cooling on larly, the change in body weight between transplantation ice. and harvesting did not differ among the groups. At the Specific cDNA products corresponding to mRNA for time of transplantation, the donor kidney weight/recipithe PDGF-A chain [16] , PDGF-B chain [17] , and ␤-actin ent body weight ratio (kw/bw) was lower in recipients [18] were amplified using the polymerase chain reaction of a female kidney as compared with animals with a (PCR). One microliter from RT reaction was taken for kidney of male origin. However, by the end of the follow-PCR, which was performed in PCR buffer (Qiagen up period, the kw/bw ratio increased to the same level in GmbM, Hilden, Germany) using 0.2 mmol/L/L of each all groups irrespective of whether animals had received a deoxynucleoside triphosphates, 1 mol/L/L of both primgraft of male or female origin. ers (Eurogentec, Kö ln, Germany), and 2.5 U thermus By week 20, prostate and vesicle were profoundly enAquaticus (Taq) DNA polymerase (Dianova). A Perkinlarged in testosterone-treated animals (M/T and F/T), Elmer Thermal Cycler (Model 9600; Perkin-Elmer, Norwhereas flutamide and finasteride resulted in a significant walk, USA) was used for amplification allowing 30 to regression of both organs. 35 cycles for each primer.
The amplified PCR product was identified by electroHistology and immunohistology phoresis on 1.5% agarose gel stained with ethidium broAt the end of the follow-up period, vehicle-treated mide. Cytokine cDNA was semiquantitated by densitoanimals (M/V, F/V), independent of donor gender, had metric comparison with ␤-actin (internal control) from developed glomerulosclerosis, tubular atrophy, interstithe same sample after the positive image was digitized by video for computerized densitometry. The results are tial fibrosis, inflammatory cellular infiltration, and inti- (Table 3 and Fig. 2) .
Administration of testosterone resulted in a markedly less pronounced in grafts of male (M/T) origin. Although the glomerulosclerosis index was significantly higher elevated degree of glomerular sclerosis (more than 40%) in recipients of a female graft (F/T) as compared with than in vehicle-treated animals (M/V), this was accompanied by a moderate accumulation of matrix proteins in vehicle-treated animals with a kidney of the same origin (F/V). Furthermore, testosterone-treated animals develthe tubulointerstitium and a slightly elevated degree of intimal proliferation in graft arteries as compared with oped a significantly higher degree of interstitial fibrosis, and a moderate tubular atrophy was observed in approxivehicle treatment (M/V). The structural changes typically associated with chronic mately 25% of the cortical tubuli. In addition, luminal obliteration of graft arteries (up to 25%) and the proliferallograft nephropathy remained suppressed, almost to the same extent, in animals treated with either flutamide Immunohistochemical analysis of graft tissues revealed mononuclear cell infiltration in all groups, localizor finasteride as compared with vehicle-treated animals regardless of donor gender. Accordingly, flutamide and ing preferentially in perivascular and periglomerular areas (Table 3) . However, while testosterone treatment finasteride treatment significantly reduced the glomerulosclerosis index, which was accompanied by well-preincreased the number of CD5ϩ T lymphocytes and ED1-positive macrophages, flutamide and finasteride reduced served tubulointerstitial architecture and no or only minor intimal thickening of graft arteries.
the number of ED1-positive macrophages, particularly . In our study, donor gender did not influence long-term allograft outcome to a major degree.
Molecular analysis
Although a decreased kw/bw ratio in recipients of a graft The intragraft mRNA expression of growth factor of female origin was noted at the time of transplantation, TGF-␤1 and PDGF-A and -B chain paralleled the develneither signs of chronic allograft nephropathy nor the opment of chronic rejection in all groups (Fig. 3 A-C) .
kw/bw ratio differed between the sexes at the end of the Accordingly, these levels were most pronounced followfollow-up. Thus, our data suggest that renal structural ing testosterone treatment. In contrast, the administradifferences between the sexes are not responsible for tion of flutamide and finasteride significantly reduced donor gender-related differences: The smaller size of growth factor levels as compared to vehicle treatment.
female grafts may represent a reduced tubular mass that No donor gender-related differences were noted. The has little influence on long-term allograft outcome. Thus, mRNA expression for interleukin (IL)-1, IL-2, IL-5, donor gender differences may be attributed to a different IL-6, IL-10, tumor necrosis factor-␣ (TNF-␣), and intersensitivity of male and female grafts to cyclosporine feron-␥ (INF-␥) remained below the limits of detection nephrotoxicity or hormones [27] . in all groups.
In contrast to donor gender, modulation of the hormonal milieu did have a significant impact on allograft outcome. We could demonstrate, to our knowledge for DISCUSSION the first time, that testosterone receptor blockade with According to the hyperfiltration hypothesis, once flutamide ameliorates the development of chronic allonephron mass is reduced to a critical level, kidney damgraft nephropathy. Another novel finding of our study age progresses as a result of hypertrophy and subsequent was that the inhibition of the conversion of testosterone sclerosis of the overworked nephrons [19] . Hyperfiltrato dihydrotestosterone with finasteride had similar benetion may contribute to the progression of chronic alloficial effects. Therefore, as testosterone and dihydrotesgraft nephropathy, as a number of experimental studies tosterone are known to bind to the same intracellular demonstrated that reduced transplanted renal mass exreceptor, dihydrotestosterone appears to mediate the aggerates allograft injury, whereas increased functional adverse effects of androgens on chronic allograft nereserve ameliorates this process [20] [21] [22] .
phropathy. In order to get additional proof for the critical For many years, donor gender-related differences in role of androgens in the rejection, we further evaluated transplantation have been explained by the hyperfiltrathe effects of testosterone. Indeed, exogenous testostertion theory. As female kidneys are smaller than males, one aggravated the rejection process, indicating that the it has been proposed that a mismatch between female elimination of this detrimental hormonal effect accounts donor kidney supply, reflected by donor kidney weight, for the better allograft outcome in antiandrogen-treated and male recipient functional demands, reflected by reanimals. These data further suggest that the inferior longcipient body weight, results in hyperfiltration-induced term outcome in male recipients observed in clinical glomerular injury and that this is responsible for the studies [4] can be explained on the basis of the male reduced survival time of female allografts [5, 6, 23] . Howhormonal background. ever, several strains of rats show no gender difference in glomerular numbers [24, 25] . Similarly, preliminary
Our results are consistent with the general hypothesis that androgens promote renal injury. Male laboratory of renal disease. Among these factors, TGF-␤ and PDGF are generally believed to play an important role in the rats of most strains have a higher susceptibility to the development of proteinuria and glomerulosclerosis, development of chronic allograft nephropathy. TGF-␤ exerts strong profibrogenic effects, stimulates mesangial whereas castrated males or female gender seem to be more resistant for these abnormalities [8] [9] [10] .
cell proliferation and regulates various inflammatory processes [37] . Enhanced TGF-␤1 mRNA and/or protein It is well established that high dietary protein intake exacerbates renal disease [19] . One may speculate that expression has been demonstrated in chronically rejected kidney allografts in animals [38] as well as in humans the anabolic effects of testosterone-induced enhanced protein intake significantly contributed to the develop- [39] . PDGF, on the other hand, consists of a disulfidelinked dimer of two polypeptides, the PDGF-A and ment of allograft injury. However, there was no difference in body weight between testosterone-and vehicle-PDGF-B chain [40] . It stimulates the proliferation of mesangial and vascular smooth muscle cells and stands treated animals. Therefore, it is unlikely that an increased protein intake was responsible for the effects of out as one of the most important agents for the promotion of the migration of smooth muscle cells from the testosterone on the development of allograft lesions.
Testosterone and dihydrotestosterone can have differarterial media into the neointima at the site of vascular rejection [41, 42] . Whether androgens stimulate the synent biological actions. For example, finasteride appears to be beneficial in the treatment of prostatic hypertrophy thesis of TGF-␤ and/or PDGF in renal tissues is unclear. However, for example, nonrenal cells such as osteoblasts [28] and male pattern hair loss [29] . In these situations, dihydrotestosterone rather than testosterone mediates respond to testosterone treatment with elevated production of TGF-␤ [43] . In our experiment, the mRNA exandrogenic effects. Nonsteroidal antiandrogens such as flutamide exert their antiandrogenic effects by inhibiting pression of TGF-␤1, PDGF-A and -B chain was profoundly up-regulated in testosterone-treated animals, androgen uptake and/or nuclear binding of androgens in target tissues [30] . Antiandrogenic compounds are which may have contributed to the more severe injury in these allografts. In contrast, antiandrogens decreased now extensively used in the palliative treatment of patients with advanced prostatic cancer [31] . Furthermore, growth factor mRNA levels in kidneys of both sexes, and this effect was associated with a better long-term testosterone-but not dihydrotestosterone-may be involved in the development of increased blood pressure outcome of these grafts. Finally, several lines of evidence indicate that gonadal in male animal models of hypertension [32, 33] . In our experiments, testosterone did not increase arterial blood steroid hormones regulate humoral and cellular immune responses [11] . Testosterone binding sites have been obpressure. The reason for this discrepancy is not clear, but it is conceivable that testosterone exacerbates hyperserved in T cells [44] as well as in macrophages [45] . Furthermore, macrophages possess 5␣-reductase activity tension in a genetically-defective regulation system, but not in an intact one. On the other hand, all animals [45] . Thus, direct effects of androgens and their inhibition on immune cells may have contributed to our results. transplanted with a kidney of female origin developed a slightly elevated systemic blood pressure by week 20.
Androgens seem to have immunosuppressive properties, as for example, in the regulation of post-traumatic immunoThis mild hypertension may have contributed to the more pronounced allograft injury observed in female depression [46] . Moreover, some earlier reports indicate that adult male rats accept allogenic skin grafts for a kidneys as compared with males among the testosteronetreated animals. However, allograft function in female considerably longer period than females [47] . In our experiment, however, graft function was not improved by kidneys derived from flutamide-and finasteride-treated rats was well preserved despite an elevated blood presthe proposed immunosuppressive effects of testosterone.
In conclusion, our data suggest that dihydrotestostersure. Thus, factors other than hypertension such as the hormonal milieu seem to be more important in determinone mediates the adverse effects of androgens on chronic allograft nephropathy. These androgens, antagonized eiing allograft function.
The mechanisms by which androgens contribute to ther by receptor blockade or the inhibition of the conversion of testosterone to dihydrotestosterone, could serve renal allograft injury remain obscure. Testosterone binding sites have been described in various tissues including as a novel therapeutic approach to prolong kidney graft survival. the kidney [34] . Furthermore, renal tissues can metabolize testosterone to dihydrotestoterone [35] . Testosterone may be a modest mitogen for mesangial cells, whereas ACKNOWLEDGMENTS it has no significant effect on collagen synthesis in these This work was made possible by a grant from BMBF/DRL (UNG/ 056/96) and OMFB/TET D-39/99. Dr. Antus is a recipient of a scholarcell type [36] .
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